Bradley Wiggins' therapeutic use exemption which allowed him to use an otherwise banned drug was ethically wrong, fellow cyclist Nicolas Roche has said, while calling for a revision to the system as TUEs are granted too easily under current regulations. Wiggins has come under scrutiny since Russian hackers 'Fancy Bears' revealed he had applied for a TUE to use a controversial corticosteroid prior to his 2012 Tour de France victory and two other road races in 2011 and 2013 when he rode for Team Sky. There is a problem with the actual system," Team Sky's Roche told cyclingnews.com.
More...